Hologic
JP Morgan Healthcare Conference Day 2: Labcorp, Thermo Fisher Scientific, Abbott, Danaher, More
Highlights of the second day included Labcorp's update on its COVID-19 testing trends and Ortho Clinical's perspective on its proposed acquisition by Quidel.Â
Hologic Preliminary Fiscal Q1 Revenues Drop 9 Percent
The firm expects fiscal Q1 Diagnostics revenues of $950.4 million, down 16 percent compared to the prior-year quarter when its COVID-19 revenues surged.
In Brief This Week: Roche, Veracyte, Hologic, Danaher, Chembio Diagnostics, Natera, and More
News items for the in vitro diagnostics industry for the week of Nov. 29, 2021.
Hologic Expects Strong Future Revenue Growth Despite Q4 Decline, 'Regardless of How COVID Evolves'
Premium
The firm's CEO said it stands to benefit from COVID-19 testing contributions if the pandemic continues and a strong base business as the pandemic weakens.
Hologic Fiscal Q4 Revenues Fall 2 Percent on Lower COVID-19 Assay Sales
Within diagnostics, molecular diagnostics revenues were $704.5 million, down 14 percent from $818.9 million in Q4 2020.
Oct 4, 2021
Sep 22, 2021
Jul 9, 2021
Jul 6, 2021
Hologic Upgraded to Outperform by Evercore ISI
Apr 30, 2021